[Clinical application of recombinant thyroid peroxidase].
TPO is a major antigen corresponding to thyroid-microsomal autoantibodies. Anti-TPO autoantibodies are very important to diagnose autoimmune thyroid disease and to estimate its clinical course. An EIA for measuring anti-TPO autoantibodies (rhTPO-EIA) was developed using recombinant human TPO expressed in CHO cells and was compared with MCHA generally used in routine laboratory work. Sera from patients with various disorders were measured for their anti-TPO autoantibodies. Chronic thyroiditis and Graves' disease were highly positive, while thyroid cancer, adenoma, SLE, and RA were low in their positivity. The positive rate of anti-TPO autoantibodies were compatible with those of previous reports of each disorder. In the comparison between rhTPO-EIA and MCHA, the correlation coefficient was 0.486. Following absorption with thyroglobulin, sera were measured again and as a result, the correlation coefficient increased to 0.723. Therefore, MCHA was thought to be influenced in the presence of anti-thyroglobulin autoantibodies. The characteristics of TPO antigen and anti-TPO autoantibodies were also summarized.
Kotani
T
T
Department of Laboratory Medicine, Miyazaki Medical College, Kiyotake, Japan.
Ohtaki
S
S
D001323:Autoantibodies / Q000032:analysis; D006111:Graves Disease / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D007453:Iodide Peroxidase / Q000276:immunology; D011994:Recombinant Proteins; D013967:Thyroiditis, Autoimmune / Q000175:diagnosis / Q000276:immunology
D001323:Autoantibodies; D011994:Recombinant Proteins; D007453:Iodide Peroxidase